China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.64
+0.31 (5.82%)
At close: Mar 27, 2026

HKG:3320 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
35,43327,95735,81032,22939,70522,303
Market Cap Growth
5.22%-21.93%11.11%-18.83%78.03%-10.80%
Enterprise Value
171,875152,391134,493125,637127,867104,251
Last Close Price
5.644.455.554.765.743.11
PE Ratio
7.886.2210.107.5910.035.92
Forward PE
7.136.577.106.118.755.81
PS Ratio
0.120.090.130.120.160.09
PB Ratio
0.270.210.340.320.440.24
P/TBV Ratio
2.011.581.781.632.091.20
P/FCF Ratio
--2.262.254.112.14
P/OCF Ratio
--1.921.883.251.74
PEG Ratio
0.630.620.620.620.620.62
EV/Sales Ratio
0.570.510.490.470.520.44
EV/EBITDA Ratio
9.928.958.648.409.688.73
EV/EBIT Ratio
11.9610.8310.5510.3411.6110.59
EV/FCF Ratio
--8.498.7513.2410.00
Debt / Equity Ratio
0.620.620.700.670.700.72
Debt / EBITDA Ratio
4.734.734.504.384.595.37
Debt / FCF Ratio
--4.634.776.616.52
Net Debt / Equity Ratio
0.480.480.440.320.420.41
Net Debt / EBITDA Ratio
3.703.702.962.212.883.22
Net Debt / FCF Ratio
--2.912.303.943.69
Asset Turnover
0.990.991.021.061.001.03
Inventory Turnover
5.605.606.307.076.997.42
Quick Ratio
0.830.831.031.000.940.95
Current Ratio
1.421.421.411.331.251.25
Return on Equity (ROE)
8.96%8.96%8.80%8.96%8.09%7.60%
Return on Assets (ROA)
2.91%2.91%2.97%2.98%2.80%2.69%
Return on Invested Capital (ROIC)
5.95%6.56%6.97%7.32%6.96%6.12%
Return on Capital Employed (ROCE)
8.80%8.80%9.50%9.80%10.40%9.20%
Earnings Yield
12.69%16.10%9.96%13.18%9.97%16.90%
FCF Yield
--44.25%44.53%24.32%46.76%
Dividend Yield
3.90%4.85%2.59%3.56%2.79%4.82%
Payout Ratio
18.84%-44.44%22.83%23.23%20.00%
Buyback Yield / Dilution
-----0.01%
Total Shareholder Return
3.90%4.85%2.59%3.56%2.79%4.83%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.